27489735|t|Phosphodiesterase type 5 inhibitors: Irrational use in Saudi Arabia
27489735|a|To identify the criteria of phosphodiesterase type 5 inhibitor (PDE5i) users and to analyse the knowledge, attitude, and practices of PDE5i use amongst Saudi men. A web - based, cross-sectional survey was conducted in Saudi Arabia between January and April 2015. Sexually active adult men were interviewed using a website questionnaire designed by the authors. Descriptive statistics were used to analyse the data. In all, 1008 men participated in the survey with 378 (37.5%) reporting use of PDE5i. Of those using PDE5i, 144 (38.1%) reported erectile dysfunction and 234 (61.9%) reported normal erection (recreational users). We found several demographic features, including high education level, health field occupation, high income, smoking, and increased frequency of sexual intercourse amongst the PDE5i users. Most of the PDE5i users (92.3%) had knowledge about PDE5i and 84.1% of them bought it without medical prescription. The most commonly used PDE5i was tadalafil (46.1%) and most of the users (79.9%) reported improvement in their sexual activity after PDE5i usage. Amongst the recreational users, the main reasons for PDE5i usage were curiosity (38.5%) and improving self-confidence (25.6%). Of them, 69.2% reported benefits from PDE5i usage, mainly in the form of enhancement of erection (36.7%) and increasing erection duration (31.2%). PDE5i use appears to be frequent in Saudi Arabia. Most of the users had knowledge about PDE5i and claimed to get benefits from it, even if used as a recreational drug.
27489735	0	35	Phosphodiesterase type 5 inhibitors	T121	C1318700
27489735	37	47	Irrational	T033	C0542058
27489735	48	51	use	T169	C0457083
27489735	55	67	Saudi Arabia	T083	C0036243
27489735	71	79	identify	T041	C0020792
27489735	84	92	criteria	T078	C0243161
27489735	96	130	phosphodiesterase type 5 inhibitor	T121	C1318700
27489735	132	137	PDE5i	T121	C1318700
27489735	139	144	users	T098	C1706077
27489735	152	159	analyse	T062	C0936012
27489735	164	173	knowledge	T170	C0376554
27489735	175	183	attitude	T041	C0004271
27489735	189	198	practices	T041	C0237607
27489735	202	207	PDE5i	T121	C1318700
27489735	208	211	use	T169	C0457083
27489735	220	229	Saudi men	T081	C0032659
27489735	233	236	web	T073	C0282111
27489735	239	244	based	T169	C1527178
27489735	246	268	cross-sectional survey	T062	C0010362
27489735	286	298	Saudi Arabia	T083	C0036243
27489735	307	314	January	T080	C3829466
27489735	319	324	April	T079	C3715024
27489735	331	346	Sexually active	T033	C0241028
27489735	347	352	adult	T100	C0001675
27489735	353	356	men	T098	C0025266
27489735	362	373	interviewed	T052	C0021822
27489735	374	379	using	T169	C0457083
27489735	382	389	website	T170	C2349146
27489735	390	403	questionnaire	T170	C0034394
27489735	420	427	authors	T097	C3812881
27489735	429	451	Descriptive statistics	T090	C0038215
27489735	457	461	used	T169	C0457083
27489735	465	472	analyse	T062	C0936012
27489735	477	481	data	T078	C1511726
27489735	496	499	men	T098	C0025266
27489735	500	512	participated	T169	C0679823
27489735	520	526	survey	T170	C0038951
27489735	544	553	reporting	T058	C0700287
27489735	554	557	use	T169	C0457083
27489735	561	566	PDE5i	T121	C1318700
27489735	577	582	using	T169	C0457083
27489735	583	588	PDE5i	T121	C1318700
27489735	602	610	reported	T058	C0700287
27489735	611	631	erectile dysfunction	T047	C0242350
27489735	648	656	reported	T058	C0700287
27489735	657	663	normal	T080	C0205307
27489735	664	672	erection	T042	C0030847
27489735	674	686	recreational	T131	C0242508
27489735	687	692	users	T098	C1706077
27489735	712	732	demographic features	T102	C0683970
27489735	744	764	high education level	T033	C1553770
27489735	766	789	health field occupation	T091	C0018722
27489735	791	802	high income	T033	C0948433
27489735	804	811	smoking	T055	C0037369
27489735	817	826	increased	T081	C0205217
27489735	827	836	frequency	T079	C0439603
27489735	840	858	sexual intercourse	T040	C0009253
27489735	871	876	PDE5i	T121	C1318700
27489735	877	882	users	T098	C1706077
27489735	896	901	PDE5i	T121	C1318700
27489735	902	907	users	T098	C1706077
27489735	920	929	knowledge	T170	C0376554
27489735	936	941	PDE5i	T121	C1318700
27489735	978	998	medical prescription	T170	C2736249
27489735	1018	1022	used	T169	C0457083
27489735	1023	1028	PDE5i	T121	C1318700
27489735	1033	1042	tadalafil	T109,T121	C1176316
27489735	1067	1072	users	T098	C1706077
27489735	1081	1089	reported	T058	C0700287
27489735	1090	1101	improvement	T077	C2986411
27489735	1111	1126	sexual activity	T053	C0036864
27489735	1133	1138	PDE5i	T121	C1318700
27489735	1139	1144	usage	T169	C0457083
27489735	1158	1170	recreational	T041	C0679105
27489735	1171	1176	users	T098	C1706077
27489735	1187	1194	reasons	T033	C0566251
27489735	1199	1204	PDE5i	T121	C1318700
27489735	1205	1210	usage	T169	C0457083
27489735	1216	1225	curiosity	T055	C0010472
27489735	1238	1247	improving	T077	C2986411
27489735	1248	1263	self-confidence	T041	C0237529
27489735	1288	1296	reported	T058	C0700287
27489735	1297	1305	benefits	T081	C0814225
27489735	1311	1316	PDE5i	T121	C1318700
27489735	1317	1322	usage	T169	C0457083
27489735	1346	1357	enhancement	T052	C2349975
27489735	1361	1369	erection	T042	C0030847
27489735	1382	1392	increasing	T169	C0442808
27489735	1393	1410	erection duration	T033	C0429828
27489735	1420	1425	PDE5i	T121	C1318700
27489735	1426	1429	use	T169	C0457083
27489735	1444	1452	frequent	T079	C0332183
27489735	1456	1468	Saudi Arabia	T083	C0036243
27489735	1482	1487	users	T098	C1706077
27489735	1492	1501	knowledge	T170	C0376554
27489735	1508	1513	PDE5i	T121	C1318700
27489735	1533	1541	benefits	T081	C0814225
27489735	1559	1563	used	T169	C0457083
27489735	1569	1586	recreational drug	T131	C0242508